Oncolytics Biotech Inc.
Oncolytics Biotech Inc. (ONCY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ONCY · as of Jun 9, 2026
Key Statistics
Explore Oncolytics Biotech Inc. Data
oncy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 80.0%
Competitors & Peers
oncy competitorsONCY
ATOS
CLNN
COYA
IMMX
MGNXStock Performance
Full HistoryAbout Oncolytics Biotech Inc.
Oncolytics Biotech Inc. is a biopharmaceutical firm in its development phase, concentrating its efforts on discovering and creating novel pharmaceutical agents to combat cancer. Its primary therapeuti…
what is oncolytics biotech inc. · oncy stock overview · oncolytics biotech inc. company profile · who is oncolytics biotech inc. ceo · oncy NASDAQ · oncolytics biotech inc. headquarters · oncolytics biotech inc. business segments
About Stock Overview & Key Data
Oncolytics Biotech Inc. (ONCY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 5, 2001. As of the latest trading session, ONCY stock price is $0.86, with a market capitalization of $85.9M. The stock has returned +88.85% over the past 12 months and -3.89% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Oncolytics Biotech Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Oncolytics Biotech Inc. reported revenue of — and net income of -$39.5M. For detailed data — including Oncolytics Biotech Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Oncolytics Biotech Inc. (ONCY) stock price is $0.86. The stock is traded on NASDAQ under the ticker symbol ONCY. The 52-week range is $0.42 – $1.51.